Ventilator-Associated Pneumonia Market Advancement, Demand, Growth Prospects Predicted by 2030
Ventilator-associated pneumonia is a respiratory disease caused to patients on ventilators. Increasing cases of respiratory diseases are expected to have a positive influence on the growth pattern of the market. According to Market Research Future (MRFR)’s study, the Ventilator-Associated Pneumonia Market is projected to reach USD 988.92 Million by 2030 at 10.2% CAGR during the forecast period 2022-2030.
The increasing cases of brain injuries
owing to accidents and other hazards are also poised to favor the proliferation
of the ventilator-associated pneumonia market over the next couple of years.
However, factors such as high ventilator charges, expensive diagnostic tests,
risks associated with ventilators, etc. are prognosticated to undermine pace of
market growth in the years to come.
Competitive Dashboard:
The Key
ventilator-associated pneumonia market players studied in this MRFR report
are Adenium Biotech ApS (Denmark), Merck & Co., Inc. (U.S.), AstraZeneca
(UK), Nabriva Therapeutics AG (Austria), and MedImmune (US).
Market Segmentation:
By diagnosis, the global ventilator-associated
pneumonia market has been segmented into radiological examination, clinical
examination, microbiological analysis, and others. The microbiological analysis
segment has been further sub-segmented into nonquantitative or
semi-quantitative airway sampling, quantitative cultures of airway specimens,
and blood and pleural fluid cultures.
On the basis of mode of treatment, the
ventilator-associated pneumonia market has been segmented into hospital
care, homecare, and others.
Based on end-user, the global
ventilator-associated pneumonia market has been segmented into research
centers, ambulatory care centers, hospitals & clinics, medical ventilator and Emergency Medical
Services (EMS).
Regional Analysis:
The global ventilator-associated pneumonia
market, on the basis of region, has been segmented into four key regions,
namely Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA).
The growth trajectory of the market is expected to be dictated by Americas
owing to the presence of a developed healthcare infrastructure coupled with
rising healthcare expenditure in North America. The region is also burdened
with a huge patient population which is prognosticated to drive the expansion
of the ventilator-associated pneumonia market in the region over the next
couple of years. Exponential growth in the population of older adults is
observed in the recent years. According to the estimations published by the
U.S. Census Bureau, Americas will have 19.7 million senior citizens by 2060.
This, in turn, is projected to boost the revenue creation of the regional
market in the years to come.
Europe is anticipated to stand firm at the
second spot in the global market place over the next few years. It has been published
by the European respiratory society, that 50% of deaths caused in the region is
due to respiratory diseases. Rising cases of respiratory disorders are likely
to have a positive influence on the expansion of the ventilator-associated
pneumonia market in the forthcoming years. Thus, the regional market’s future
trajectory is likely to remain highly lucrative over the next few years.
Asia Pacific exhibits favorable
opportunities for the development of the ventilator-associated pneumonia market
over the next couple of years, thus, making it the fastest growing regional
segment in the global market. The growth of the region can be ascribed to
rising healthcare expenditures wowing to the economic development of the
region. In addition, the advancements in the healthcare sector of Asia Pacific
is also expected to accelerate revenue creation for the participants of the
market. The increasing population of the region is anticipated to lead the
growth of the patient population, which in turn, is expected to support the
expansion of the market in the region in the years to come. Also, the geriatric
population of the region is poised to influence the expansion of the regional
market positively in the forthcoming years. According to the Asian Development
Bank (ADB), the geriatric population of the region is anticipated to exceed 923
million mark by 2050.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
https://geto.space/read-blog/129617
Comments
Post a Comment